| ||||||||||||||
| Homozygous CdonlacZ-2 (or CdolacZ-2) mice harbor a beta-galactosidase (lacZ) "knock-in" mutation that also abolishes expression of the targeted Cdon (cell adhesion molecule-related/down-regulated by oncogenes) gene. This strain may be useful in studying holoprosencephaly (HPE; a common defect of human forebrain development), craniofacial/brain development and the regulation of Sonic Hedgehog (Shh) signaling pathways. | ||||||||||||||
Type Mutant Stock; Targeted Mutation; Additional information on Genetically Engineered and Mutant Mice. Visit our online Nomenclature tutorial. Species laboratory mouse Donating Investigator Robert Krauss, Mount Sinai School of Medicine Description
Homozygous CdonlacZ-2 (or CdolacZ-2) mice on a "129/Sv" genetic background are viable and fertile, harboring a beta-galactosidase (lacZ) "knock-in" mutation that also abolishes targeted gene expression. LacZ expression mimics the pattern observed for the endogenous gene. On a 129/Sv background, Cdo-deficient mice exhibit craniofacial midline defects identified as microforms of holoprosencephaly (HPE; a common defect of human forebrain development) with partial penetrance, grossly normal limb development and no perinatal lethality. These CdonlacZ-2 (or CdolacZ-2) mice are a genetic model of HPE and may be useful in studying craniofacial/brain development and the regulation of Sonic Hedgehog (Shh) signaling pathways, as well as for lacZ expression in Cdo-expressing tissues.In an attempt to offer alleles on well-characterized or multiple genetic backgrounds, alleles are frequently moved to a genetic background different from that on which an allele was first characterized. It should be noted that the phenotype of these mutant mice could vary from that originally described. For example, the penetrance and expressivity of HPE phenotypes for Cdo-deficient mice is dependent upon genetic background: homozygotes on the C57BL/6 genetic background display severe semilobar HPE and cebocephaly and perinatal lethality with high penetrance, while homozygotes on a mixed 129/Sv x C57BL/6 genetic background display craniofacial microforms of HPE with high penetrance and partial perinatal lethality.
Development
A targeting vector was designed to insert an IRES-lacZ reporter gene (internal ribosome entry site, beta-galactosidase, GTI-2 promoter-neo cassette and polyA sequence) into the third coding exon of the targeted gene. The donating investigator reports that the construct was electroporated into (129X1/SvJ x 129S1/Sv)F1-derived R1 embryonic stem (ES) cells, and chimeric males were bred with 129S6/SvEvTac females to obtain mutant animals. These mutant mice were maintained mostly by heterozygous intercross (with some wildtype or 129S6/SvEvTac breedings possible as well) for many generations prior to arrival at The Jackson Laboratory. Upon arrival at The Jackson Laboratory, these mice were bred to 129S1/SvImJ inbred mice (Stock No. 002448) for at least one generation to establish the colony.
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 002448 129S1/SvImJ | (approximate) | |
| Considerations for Choosing Controls | ||
lacZ Expression Strains
View lacZ Expression Strains (186 strains)
Fluorescent Proteins/lacZ Systems
View Related Disease (OMIM) Terms
Related Disease (OMIM) Terms
Holoprosencephaly - Models with phenotypic similarity to human disease where etiologies are distinct.2
2 Human genes are associated with this disease. Orthologs of those genes do not appear in the mouse genotype(s).
View Mammalian Phenotype Terms
Mammalian Phenotype Terms
assigned by genotype
The following phenotype information may relate to a genetic background differing from this JAX® Mice strain.
Cdontm2Rsk/Cdontm2Rsk
involves: 129/Sv * C57BL/6
- lethality-prenatal/perinatal
- neonatal lethality (MGI Ref ID J:82221)
- exhibit a similar range and frequency of neonatal lethality as Cdontm1Rsk homozygotes
- lethality-postnatal
- postnatal lethality (MGI Ref ID J:82221)
- exhibit a similar range and frequency of lethality as Cdontm1Rsk homozygotes
- growth/size phenotype
- decreased body size (MGI Ref ID J:82221)
- craniofacial phenotype
- abnormal craniofacial morphology (MGI Ref ID J:82221)
- about 95% of mutants exhibit craniofacial abnormalities
- abnormal incisor morphology (MGI Ref ID J:82221)
- mutants either have a single, central maxillary incisor or no maxillary incisors
- abnormal lip morphology (MGI Ref ID J:82221)
- dysgenesis of the philtrum
- abnormal palate morphology (MGI Ref ID J:82221)
- lack a primary palate
- abnormal premaxilla morphology (MGI Ref ID J:82221)
- fusion of the premaxillary bone, resulting in severe pyriform aperture stenosis
- basisphenoid bone foramen (MGI Ref ID J:82221)
- small basisphenoid bone (MGI Ref ID J:82221)
- skeleton phenotype
- abnormal premaxilla morphology (MGI Ref ID J:82221)
- fusion of the premaxillary bone, resulting in severe pyriform aperture stenosis
- basisphenoid bone foramen (MGI Ref ID J:82221)
- small basisphenoid bone (MGI Ref ID J:82221)
- respiratory system phenotype
- abnormal nose morphology (MGI Ref ID J:82221)
- increase in presumptive mesenchyme between the nasal capsule and the oral cavity
- although medial nasal process (MNP) fusion occurs normally at E11.5, later stage embryos maintain an epithelialized furrow at the MNP midline and have a recessed inferior border
- abnormal nasal septum morphology (MGI Ref ID J:82221)
- nasal septum is reduced in size and there is agenesis or hypoplasia of the nasal septal cartilage
- digestive/alimentary phenotype
- abnormal palate morphology (MGI Ref ID J:82221)
- lack a primary palate
- nervous system phenotype
- holoprosencephaly (MGI Ref ID J:82221)
- microform holoprosencephaly
Cdontm2Rsk/Cdontm2Rsk
B6.129-Cdontm2Rsk
- lethality-prenatal/perinatal
- perinatal lethality (MGI Ref ID J:109070)
- homozygotes that develop holoprosencephaly (80-85%) die perinatally
- life span-post-weaning/aging
- premature death (MGI Ref ID J:109070)
- 15 to 20% do not exhibit overt signs of holoprosencephaly and survive beyond the perinatal period, but die within 4-12 weeks of birth
- nervous system phenotype
- abnormal brain ventricle morphology (MGI Ref ID J:109070)
- enlarged lateral ventricles (MGI Ref ID J:109070)
- mutants that survive the postnatal period have enlarged lateral ventricles with a disruption of the septum, consistent with hydrocephalus
- abnormal forebrain morphology (MGI Ref ID J:109070)
- mutants that survive the postnatal period exhibit highly enlarged forebrains with dilated blood vessels and olfactory bulbs
- mutants that survive the postnatal period exhibit an enlarged gap between the hypothalamus and pons, indicating a slight truncation of the forebrain
- abnormal cerebral cortex morphology (MGI Ref ID J:109070)
- the dorsal midline of cortices exhibit an abnormal structure, lacking the lamina terminalis
- thin cerebral cortex (MGI Ref ID J:109070)
- the posterior telencephalon of E18.5 brains shows a translucent appearance, indicating thinning of the cortex
- variable severity of cortical thinning; mutants with holoprosencephaly exhibit the most severe thinning
- enlarged lateral ventricles (MGI Ref ID J:109070)
- mutants that survive the postnatal period have enlarged lateral ventricles with a disruption of the septum, consistent with hydrocephalus
- abnormal neuronal precursor proliferation (MGI Ref ID J:109070)
- primary neural progenitor cells from E14.5 cortices display a reduced proliferation rate
- holoprosencephaly (MGI Ref ID J:109070)
- 80-85% develop severe forms of holoprosencephaly
- hydroencephaly (MGI Ref ID J:109070)
- mutants that survive the postnatal period develop hydroencephaly
- craniofacial phenotype
- domed skull (MGI Ref ID J:109070)
- mutants that survive the postnatal period have a dome-shaped head
- cardiovascular system phenotype
- abnormal blood vessel morphology (MGI Ref ID J:109070)
- dilated blood vessels in the enlarged forebrain
- hemorrhage (MGI Ref ID J:109070)
- mutants that survive the postnatal period have brains that display surface bleeding
- behavior/neurological phenotype
- weakness (MGI Ref ID J:109070)
- mutants that survive the postnatal period show limb weakness and immobility
- skeleton phenotype
- domed skull (MGI Ref ID J:109070)
- mutants that survive the postnatal period have a dome-shaped head
View Research Applications
Research Applications
This mouse can be used to support research in many areas including:
Cell Biology Research
Signal Transduction
Developmental Biology Research
Craniofacial and Palate Defects
Internal/Organ Defects
brain
Neurobiology Research
lacZ expression in neural tissue
Research Tools
lacZ Expression
Genetics Research
Tissue/Cell Markers
| Allele Symbol | Cdontm2Rsk | ||
|---|---|---|---|
| Allele Name | targeted mutation 2, Robert S Krauss | ||
| Allele Type | Targeted (Reporter) | ||
| Common Name(s) | CdonlacZ-2; | ||
| Mutation Made By | Robert Krauss, Mount Sinai School of Medicine | ||
| Strain of Origin | 129/Sv | ||
| Gene Symbol and Name | Cdon, cell adhesion molecule-related/down-regulated by oncogenes | ||
| Chromosome | 9 | ||
| Gene Common Name(s) | CAM-related/down-regulated by oncogenes; CDO; MGC111524; ORCAM; | ||
| Molecular Note | An IRES-lacZ-neo cassette was inserted at the 3' terminus of exon 3. Endogenous protein was undetected by Western blot analysis of homozygous mutant mice. Beta-galactosidase activity was detected by staining. [MGI Ref ID J:82221] | ||
This strain will not have a genotyping protocol or one is not currently available.
Helpful Links
Genotyping resources and troubleshooting
Cole F; Krauss RS. 2003. Microform Holoprosencephaly in Mice that Lack the Ig Superfamily Member Cdon. Curr Biol 13(5):411-5. [PubMed: 12620190] [MGI Ref ID J:82221]
Tenzen T; Allen BL; Cole F; Kang JS; Krauss RS; McMahon AP. 2006. The cell surface membrane proteins Cdo and Boc are components and targets of the Hedgehog signaling pathway and feedback network in mice. Dev Cell 10(5):647-56. [PubMed: 16647304] [MGI Ref ID J:108747]
Zhang W; Kang JS; Cole F; Yi MJ; Krauss RS. 2006. Cdo functions at multiple points in the Sonic Hedgehog pathway, and Cdo-deficient mice accurately model human holoprosencephaly. Dev Cell 10(5):657-65. [PubMed: 16647303] [MGI Ref ID J:108746]
Cdontm2Rsk relatedAllen BL; Tenzen T; McMahon AP. 2007. The Hedgehog-binding proteins Gas1 and Cdo cooperate to positively regulate Shh signaling during mouse development. Genes Dev 21(10):1244-57. [PubMed: 17504941] [MGI Ref ID J:121553]
Cole F; Zhang W; Geyra A; Kang JS; Krauss RS. 2004. Positive regulation of myogenic bHLH factors and skeletal muscle development by the cell surface receptor CDO. Dev Cell 7(6):843-54. [PubMed: 15572127] [MGI Ref ID J:95029]
Zhang W; Yi MJ; Chen X; Cole F; Krauss RS; Kang JS. 2006. Cortical thinning and hydrocephalus in mice lacking the immunoglobulin superfamily member CDO. Mol Cell Biol 26(10):3764-72. [PubMed: 16648472] [MGI Ref ID J:109070]
Colony Maintenance
Breeding & Husbandry When maintaining a live colony of CdonlacZ-2 on the 129/Sv genetic background, the donating investigator breeds heterozygous mice together.
| Pricing for USA, Canada and Mexico shipping destinations |
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $1900.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Pricing for International shipping destinations |
|
Animals Provided
Price (US dollars $) Cryorecovery Fee $2470.00 At least two mice that carry the mutation (if it is a mutant strain) will be provided. Their genotypes may not reflect those discussed in the strain description. Please inquire for possible genotypes and see additional details below.
| Standard Supply | Cryopreserved. Ready for recovery. Please refer to pricing and supply notes for further information. |
|---|---|
| Supply Notes |
|
| Control | ||
|---|---|---|
| Wild-type from the colony | ||
| 002448 129S1/SvImJ | (approximate) | |
| Considerations for Choosing Controls | ||
| USA, Canada and Mexico - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
| International - Control Pricing Information for Genetically Engineered Mutant Strains. | ||
Purchasing Information
JAX® Mice Orders
Surgical Services
Contact Information
Orders & Technical Support
Tel: 1-800-422-6423 or 1-207-288-5845
Fax: 1-207-288-6150
Technical Support Email Form
| phone: | 207-288-6470 |
| fax: | 207-288-6655 |
MICE, PRODUCTS AND SERVICES ARE PROVIDED “AS IS”. JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.
In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.
In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. In purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.
MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.
The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.
Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.